PhoenixBio Competitors and Similar CompaniesClear all
PhoenixBio's competitors and similar companies include FibroGen and SingletO2 Therapeutics.
 PhoenixBio PhoenixBio (株式会社フェニックスバイオ) is a company that provides contract study services for drug discovery and development. |  FibroGen FibroGen is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to treat serious unmet medical needs. |  SingletO2 Therapeutics SingletO2 Therapeutics is a company engaged in developing treatments for periodontal disease. | |
Founding Date | Founding Date 2002 | Founding Date 1993 | Founding Date 2015 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Higashihiroshima, JP HQ New York, US | Locations San Francisco, US HQ | Locations Summit, US HQ |
Employees | Employees 70 | Employees 53115% increase | Employees 2 |
Valuation ($) | Valuation ($) 10.9 m | Valuation ($) 30.7 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) ¥1.6b (FY, 2026) | Revenue (est.) $6.4m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods ¥342.7m (FY, 2026) | Cost of goods $556k (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit ¥1.2b (FY, 2026) | Gross profit $5.9m (FY, 2025) | Gross profit N/A |
Net income | Net income ¥125.2m (FY, 2026) | Net income $183.5m (FY, 2025) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
FibroGen
HQ
San Francisco, US
Employees
531↑ 15% increase
FibroGen is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to treat serious unmet medical needs.
View companySingletO2 Therapeutics
HQ
Summit, US
Employees
2
SingletO2 Therapeutics is a company engaged in developing treatments for periodontal disease.
View company